Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition

scientific article published on 22 March 2017

Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JVI.00012-17
P932PMC publication ID5432861
P698PubMed publication ID28331083

P50authorAndrew BadleyQ43134987
Nathan W CumminsQ88334168
Sekar NatesampillaiQ117792587
P2093author name stringScott Kaufmann
Fatma Aboulnasr
Amy M Sainski-Nguyen
P2860cites workBcl-2 maintains B cell memoryQ24308796
Amino-terminal polypeptides of vimentin are responsible for the changes in nuclear architecture associated with human immunodeficiency virus type 1 protease activity in tissue culture cellsQ24599011
Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosinQ24676673
Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplantQ27323780
BH3-only proteins: a 20-year stock-takeQ28085220
Activation of the NF-kappaB pathway by caspase 8 and its homologsQ28139456
HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentationQ28211642
Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activationQ28248512
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationQ29619611
Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replicationQ33332152
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin LymphomaQ33438494
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activationQ33508788
Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41.Q33566570
Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2Q37356313
A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemiaQ37577524
Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment.Q38398064
HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligandQ38457134
The deadly landscape of pro-apoptotic BCL-2 proteins in the outer mitochondrial membraneQ38668186
A Comparison of Real-Time and Endpoint Cell Viability Assays for Improved Synthetic Lethal Drug Validation.Q38834329
HIV-1 protease-induced apoptosisQ38989333
Targeting BCL2 With BH3 Mimetics: Basic Science and Clinical Application of Venetoclax in Chronic Lymphocytic Leukemia and Related B Cell MalignanciesQ38996888
Anti-HIV designer T cells progressively eradicate a latently infected cell line by sequentially inducing HIV reactivation then killing the newly gp120-positive cellsQ39090535
Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir SizeQ39599213
Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapyQ39748924
Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo studyQ40668686
U937 cells overexpressing bcl-xl are resistant to human immunodeficiency virus-1-induced apoptosis and human immunodeficiency virus-1 replicationQ40965823
The inhibition of pro-apoptotic ICE-like proteases enhances HIV replicationQ41125440
bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferationQ41964290
Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat proteinQ45749420
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cellsQ45788521
The Remarkable Stability of the Latent Reservoir for HIV-1 in Resting Memory CD4+ T Cells.Q50740811
Down-regulation of IL-7Ralpha expression in human T cells via DNA methylation.Q51976103
A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers.Q53582191
Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitroQ68111216
IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2Q71727879
Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy.Q33823310
Intracellular Casp8p41 content is inversely associated with CD4 T cell countQ34004148
Human immunodeficiency virus envelope protein Gp120 induces proliferation but not apoptosis in osteoblasts at physiologic concentrations.Q34024085
Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activityQ34150316
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic LeukemiaQ34504188
Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 casesQ34539993
Bcl-2 upregulation by HIV-1 Tat during infection of primary human macrophages in cultureQ34577364
HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cellsQ34672568
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.Q34985945
Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cellsQ35111879
The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/BakQ35140447
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cellsQ35202343
T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesisQ35543827
HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells.Q35661660
In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized MiceQ35760429
Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infectionQ35837788
bc1-2 expression facilitates human immunodeficiency virus type-1 mediated cytopathic effects during acute spreading infectionsQ35864541
Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivoQ35914355
Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV TherapyQ35965172
Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switchQ36125264
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infectionQ36225040
The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDSQ36400220
Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivationQ36409885
Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral TherapyQ36481572
Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivoQ36607484
Interleukin-7 promotes HIV persistence during antiretroviral therapyQ36873277
Persistent HIV-1 replication maintains the tissue reservoir during therapyQ36897321
Analysis of HIV Protease Killing Through Caspase 8 Reveals a Novel Interaction Between Caspase 8 and MitochondriaQ36901485
HIV Protease Cleavage of Procaspase 8 is Necessary for Death of HIV-Infected CellsQ36901499
Altering cell death pathways as an approach to cure HIV infectionQ37062057
Negative Feedback Regulation of HIV-1 by Gene Editing StrategyQ37177251
Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab).Q37312736
Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving SuppresQ37347313
P433issue11
P407language of work or nameEnglishQ1860
P577publication date2017-03-22
P1433published inJournal of VirologyQ1251128
P1476titleMaintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition
P478volume91

Reverse relations

cites work (P2860)
Q88866382Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4+ T Cells
Q41930599Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins
Q89574422BCL-2 antagonism sensitizes cytotoxic t cell-resistant hiv reservoirs to elimination ex vivo
Q92637590Block-And-Lock Strategies to Cure HIV Infection
Q47555333Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV.
Q52324513HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the Proteasome.
Q41921236HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim.
Q92857802Have Cells Harboring the HIV Reservoir Been Immunoedited?
Q52571192Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12-15 December 2017, Miami, FL, USA.
Q47550536Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.
Q97067038Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening
Q47566696Recent progress in understanding HIV reservoirs
Q92537912Specific Biological Features of Adipose Tissue, and Their Impact on HIV Persistence
Q92300043Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs
Q90211132Telomerase Biology Associations offer Keys to Cancer and Aging Therapeutics

Search more.